Wang Junjie.Review of tumor radiosensitivity from the point of view of stereotactic ablative radiotherapy[J].Chinese Journal of Radiological Medicine and Protection,2018,38(12):881-885
Review of tumor radiosensitivity from the point of view of stereotactic ablative radiotherapy
Received:June 18, 2018  
DOI:10.3760/cma.j.issn.0254-5098.2018.12.001
KeyWords:Stereotactic ablative radiotherapy (SABR)  Tumar  Radiosensitivity
FundProject:
Author NameAffiliation
Wang Junjie Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China 
Hits: 2488
Download times: 1622
Abstract::
      With the technical advances, radiotherapy has ushered in a new era of 3-D and 4D, which are associated with significantly improved therapy precision and profound change in fractionation pattern. The radiotherapy with focused rays, represented by both 3D-conformal radiotherapy (3D-CRT) and intensity modulated radiation therapy (IMRT), involves the delivery of high doses to the target volume, with a less attendant potential for damages to surrounding normal tissue. Radiotherapy has been able to deliver precise, efficient, low toxic access to therapeutic effects thanks to the advance in image-guided techniques, the combination of radiotherapy equipment with image-guided system, the availability of target position information before radiotherapy with 3D or 4D image modality, the stereotactic body radiation therapy (SBRT)/the stereotactic ablation radiosurgery (SABR). Conventional fractionated radiation has seen the therapeutic effect of convincing and promising. The conventional theory of radiobiology, which deems the tumor not sensitive to radiotherapy to have good reaction with SABR, has been unable to explain the mechanism of antitumor effects arising from such exposure modes. Therefore, it is now urgent to create new radiobiological theory and system for radiotherapy in order to better illustrate the principle and mechanism of new technologies, to establish its internal relation with conventional radiobiology and to lay theoretical groundwork for popularization and dissemination of SABR in clinical medicine.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9062267  On-line:0

v
Scan QR Code
&et=3E9ABE53C150E27D9D8E2D099963A631440384D4247CFF6DB5B3E346102B4D55294A89101261151785E4A8FC5F8AB4A09DF341952AAC9ADF1DF4346BEF2A1C896745F785F7006EA7CB8AB89A607A09EFC17C2978D90B91075A49C59528AA3030&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=EA357AD73C8E13BC&aid=BC4A7A631EF4C499F9508294E38C0F63&vid=&iid=59906B3B2830C2C5&sid=E348995F86F60FD3&eid=745C7FAEA69986C7&fileno=20181201&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="EA357AD73C8E13BC"; var my_aid="BC4A7A631EF4C499F9508294E38C0F63";